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European Journal of Obstetrics & Gynecology and
Reproductive Biology 124 (2006) 178–183AbstractObjective: This study was performed to determine the prevalence of GBS and to identify GBS colonisation risk factors in a multicultural
population of pregnant women in The Netherlands. We calculated predictive values of cultures in pregnancy for intrapartum GBS carriage.
Study design: From a total of 1702 women visiting several antenatal outpatient departments, rectovaginal swabs were collected at 35–37
weeks’ gestation. In 761 women swabs were repeated at time of delivery. Carriage of GBS late in third trimester and at time of delivery was
analysed in relation to age, parity, ethnicity and socio-economic status.
Results: Twenty-one percent was GBS carrier late in pregnancy. Compared to Europeans, African women were at a higher risk (29%, RR 1.4,
CI 1.1–1.7) and Asian women were at lower risk (13%, RR 0.6, CI 0.4–0.8) for GBS carriage. No differences in colonisation were found
between women with respect to age, parity or socio-economic background. Positive predictive value of GBS carriage at 35–37 weeks’
gestation for carriage at time of parturition was 79% and negative predictive value was 93%.
Conclusions: It was not possible to identify a group of pregnant women at high risk for GBS colonisation. Predictive values of antenatal
genital group B streptococci cultures at 35–37 weeks’ gestation for intrapartum GBS carriage are lower than previously reported.
# 2005 Published by Elsevier Ireland Ltd.
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Since the 1970s, Group B Streptococcus (GBS,
Streptococcus agalactiae) has been recognised as the most
important infectious cause of morbidity and mortality in
newborn infants. Despite the decrease in mortality during
the last decades, early onset GBS disease remains a serious
neonatal condition, which may cause severe neurological
damage. In The Netherlands, the incidence of early onset
GBS disease in 1997–1998 was estimated at 1.9 per 1000* Corresponding author. Tel.: +31 70 3302066; fax: +31 70 3889964.
E-mail address: a.valkenburg@mchaaglanden.nl
(A.W. Valkenburg-van den Berg).
0301-2115/$ – see front matter # 2005 Published by Elsevier Ireland Ltd.
doi:10.1016/j.ejogrb.2005.06.007live births, with a case fatality rate of 5% [1]. GBS
transmission is vertical from mother to child. The
gastrointestinal tract is the source of vaginal GBS colonis-
ation and many adults are colonised with GBS without
showing symptoms. Approximately 10–30% of women of
childbearing age carries GBS in the rectovaginal compart-
ment [2–4]. The prevalence may vary due to differences in
the culture technique, the location and number of sites
cultured and the population studied [2]. A role for ethnic or
genetic factors is presumed, since Caribbean Hispanics and
black women were reported to be GBS carriers more
frequently [2,5,6].
Dutch data originate from studies by Gerards in 1985 and
Adriaanse in 1995, in which overall carrier rates of 14% in
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have been described.
In the United States, revised consensus guidelines regard-
ing the management of GBS were published in 2002. These
guidelines recommend screening of all pregnant women for
GBS carriage at 35–37 weeks’ gestation and intrapartum
treatment of those women with positive cultures [9].
The Dutch Society of Obstetrics and Gynaecology and
the Dutch Society of Pediatrics [10] recommend intrapartum
maternal administration of antibiotics in women with
intrapartum temperature > 37.8 8C, in women with GBS
bacteriuria during current pregnancy and in women who
previously gave birth to an infant with early onset GBS
disease, irrespective to their GBS status. In women
presenting with any of the other risk factors associated
with early onset GBS disease, i.e. delivery at <37 weeks’
gestation or rupture of membranes for more then 24 h,
screening for GBS carriage is performed first, followed by
chemoprophylaxis when the culture is positive. In case the
delivery occurs before the result is available, the obstetrician
should decide about antibiotic prophylaxis, based on the
severity of the risk factor [11]. The choice for this risk factor-
based strategy was made in 1998, with the intention to
reduce the number of women that receives prophylactic
antibiotics [11], taking account of the Dutch organisation of
obstetrical care with approximately 30% home deliveries.
The disadvantages of this strategy are, that 30–40% of
neonatal early onset GBS infections may occur in the
absence of risk factors [1] and that in most cases delivery
occurs before culture results are available.
The best preventive strategy maximises treatment in
women who need it, and minimises treatment in women who
do not need it. To be able to optimise the strategy it is
essential to know the prevalence of GBS colonisation of
pregnant women in The Netherlands, which may have
changed due to recent changes in demographics, in
particular with regard to ethnic background of women
living in major cities. The aim of this study was to ascertain
GBS carrier-rate late in pregnancy in a multicultural, urban
population in The Netherlands, to find out if a group of high
risk for GBS colonisation could be identified and to calculate
positive and negative predictive values for intrapartum
carriage, based on results of the cultures at 35–37 weeks’
gestation.2. Methods
In The Hague, approximately 8000 deliveries take place
annually. Almost all hospitals and a part of midwifery
practices joined this study. Between July 2000 and
December 2002, physicians and midwives at their discretion
non-selectively asked women at 35–37 weeks of pregnancy
to participate in the study. All these women attended either
the outpatient department of obstetrics and gynaecology at
the Medisch Centrum Haaglanden, the Leyenburg Hospital,the Rode Kruis Hospital or one of the six participating
midwifery practices in The Hague, The Netherlands.
After informed consent, the physician or midwife
collected a rectovaginal swab for GBS culture by initially
swabbing the vaginal introı̈tus and thereafter the rectum
(through the anal sphincter). Swabs were placed in a
transport medium (amies transport medium with charcoal)
and sent to one of the participating laboratories. Inoculation
took place at 35–37 8C for 18–24 h into a selective broth
medium (Todd–Hewitt supplemented with gentamycin
(8 mg/ml) and nalidixid acid (15 mg/ml)). The broth was
subcultured onto a blood agar under anaerobic circum-
stances and GBS suspected colonies were then Gram-
stained. A catalase reaction was performed for all Gram
positive cocci. On all catalase negative colonies, a
streptococcus grouping latex agglutination test (PathoDx
group B, Diagnostic Products Corporation, Los Angeles,
USA) was performed to identify GBS. The results were
reported to the participating antenatal clinics and midwifery
practices. Colonised women received intrapartum antibio-
tics only when one or more of the risk factors associated with
early onset GBS disease was present. The initial intention
was to repeat GBS cultures during labour in all GBS positive
women and in 400 of GBS negative women.
All women were asked to complete a questionnaire about
ethnic, demographic and socio-economic factors and obstetric
details. Age, parity, postal code and the country of birth of both
the woman and her parents were registered. The participants
were grouped into different demographic and socio-economic
categories by using the classification systems of the Municipal
Information Centre of TheHagueand theCentral Commission
for Statistics in The Netherlands (Statistics Netherlands/CBS)
and into different ethnic categories by using publications
published by the Ministry of the Interior and Kingdom
Relations (BZK) and information acquired from the United
Nations. The country of birth was used to classify the women
into ethnic groups according to the Dutch standard identifica-
tion method [12]. These ethnic groups are class A: born in
The Netherlands or coming from one of the developed
countries; class B: coming from any less developed country
(Table 2B).
A protocol was formulated to screen 2100 women from
The Hague, classified into different ethnic and socio-
economic groups: Group 1: class A and living in the inner city (lower socio-
economic group). Group 2: class B and living in the inner city.
 Group 3: class A and living in the suburbs (higher socio-
economic group). Group 4: class B and living in the suburbs.
Although we initially planned to include 2100 women,
we found that after 2 years and 5 months 1700 women were
included, and that no additional information would be
gained by continuation of the inclusion period.
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Table 2A
GBS carrier rates according to origin and where people lived in The Hague,
The Netherlands
Rate % 95% CI
Class A
Inner city 29/174 17 0.11–0.23
Suburb 129/569 23 0.19–0.26
Unknown 1/2
Total 159/745 21 0.18–0.24
Class B
Inner city 104/471 22 0.18–0.26
Suburb 88/427 21 0.17–0.25
Unknown 2/6We estimated the prevalence of positive cultures as the
proportion of positive testing women over all women, with
95%-confidence intervals based on a binomial distribution.
These calculations were performed for various subgroups,
and prevalences were compared by calculating relative risks
(prevalence ratios), with 95%-confidence intervals based on
a Poisson distribution of the positive tests.
Positive and negative predictive values for intrapartum
carriage, based on the results of the cultures collected at
35–37 weeks pregnancy, were calculated.
The medical ethics committees of the participating
hospitals approved the protocol for this study.







Inner city 134/657 20 0.17–0.23
Suburb 225/1032 22 0.19–0.23
Unknown 6/13
Total 365/1702 21 0.19–0.233. Results
During the study period, a total of 1702 pregnant women
were enrolled. Mean age was 30.5 years, median was 31
years (range 14–45 years). Four hundred and sixty-six
women were primigravida and 1225 women were multi-
gravida, while data about parity were missing in 11 cases.
Six hundred and ninety-two women were Dutch and had
parents who were both born in The Netherlands, the
remaining women had at least one parent born in a foreign
country or were born in another country themselves. The
ethnic origin of 53 women was unknown. Of the 1702
women, 365 (21%) had positive cultures for Group B
Streptococcus at 35–37 weeks of gestation. There was no
relationship between colonisation and age, parity or
miscarriages (Table 1). Tables 2A and 2B shows the
breakdown of women by classification in group A or B,
living in the inner city or the suburbs and the percentage of
GBS carriage found per group. The prevalence of GBS
carriage in classes A and B were identical: 21%. We then
analysed whether the place where women lived (inner city or
the suburbs) affected the prevalence of GBS colonisation. OfTable 1
Age, parity, history of abortions and GBS culture results
N % GBS positive 95% CI
Age
<20 41 32 0.18–0.46
20–29 663 17 0.14–0.20
30–39 905 24 0.21–0.27
40 92 25 0.16–0.34
Unknown 1 100
Parity
0 663 21 0.18–0.24
1 645 19 0.16–0.22
2 232 29 0.23–0.35
3 or more 181 22 0.16–0.28
Unknown 11 18
History of abortions
0 1163 21 0.20–0.21
1 or 2 470 22 0.18–0.26
3 or more 58 22 0.11–0.33
Unknown 11 18the 1702 women, 657 lived in the inner city and 1032 lived in
the suburbs. Prevalence in these groups was 20% and 22%,
respectively. The place of residence of 13 women was
unknown.
Participating women originated from 72 different
countries. When using United Nations world region
classifications to cluster these countries, differences in
GBS carriage between the women of these various countries
of birth become apparent (Table 3). In women originating
from countries in Europe and Latin America we found a
colonisation rate of 21% compared to colonisation rates of
29% in African women and 13% in Asian women. Women
born in Africa had an increased risk for colonisation
compared with European women (RR 1.4, CI 1.1–1.7),
whereas Asian women had a reduced risk for GBS carriage
compared to European women (RR 0.6, CI 0.4–0.8).
In 173 of the 365 GBS positive women and in 588 of the
1337 GBS negative women, cultures were repeated at
delivery. In 174 (23%) of these 761 women, cultures were
positive at this time.Table 2B
Classification in class A or B according to country of birth
Country
Class A The Netherlands, Belgium, Canada, Denmark,
Germany, Finland, France, Greenland, United Kingdom,
Ireland, Iceland, Israel, Japan, Channel Islands, Liechtenstein,
Luxembourg, Monaco, Dutch East Indies, Dutch Newguinea,
Newfoundland, New Zealand, Norway, Austria,
United States of America, Sweden, Switzerland
Class B All other countries
Class A: women of Dutch origin or coming from one of the developed
countries; class B: women coming from one of the other countries.
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Table 3
World regions and GBS culture results
Continent of native country N % GBS
positive
95% CI
Africa 240 29 0.23–0.35
Asia 256 13 0.09–0.17
Latin America 245 22 0.17–0.27
Europe 907 21 0.18–0.24
Other 10 30 0.015–0.58
Unknown 44 27 0.14–0.40
Total 1702 27
Table 5
Studies with rectovaginal GBS cultures on selective broth medium in third
trimester of pregnancy
Reference Year Country N Prevalence
GBS (%)
Dillon et al. [26] 1982 United States 754 28
Easmon et al. [16] 1985 United Kingdom 895 19.8
Sunna et al. [21] 1991 Jordan 500 30.4
Yancey et al. [4] 1996 United States 826 26.5
Grimwood et al. [3] 2002 New Zealand 240 22
This study 2003 The Netherlands 1702 21Table 4 shows the proportion of women with positive and
negative intrapartum cultures in relation to the results of the
first swab taken between 35–37 weeks’ pregnancy. Of all the
pairsofcultures,136of173womenwhowerepositiveat35–37
weeks gestation were also positive at delivery (positive
predictive value 79%) and 550 of 588 women who were
initially negative, remained negative at delivery (negative
predictive value 93%). Thirty-eight women acquired GBS in
the last weeks of pregnancy, whereas cultures in 37 previously
positive women were negative at delivery.4. Comment
In this study we show that in the multicultural, urban
population of pregnant women in The Hague, The
Netherlands, the GBS carrier rate is 21%. We showed
differences between colonised and non-colonised women in
ethnicity, but we could not demonstrate differences between
colonisedandnon-colonisedwomenwithrespect toage,parity
or socio-economic background. Positive predictive value of
GBS carriage at 35–37 weeks’ gestation for carriage at time of
parturition was 79% and negative predictive value was 93%.
The large number of women in our study distinguishes
this study from other GBS prevalence studies. Table 5
presents other studies in which pregnant women were
cultured rectovaginal at about 35–37 weeks’ gestation with
the use of selective broth media.
In previous studies, GBS carriage prevalences between
1.6% and 30.4% have been described [2–5,7,8,13–26]. The
differences in these prevalences can probably be explained
by the different gestational ages at culturing, differences in
culture site and in the use of different culture techniques.Table 4








Positive 136 37 173
Negative 38 550 588
Total 174 587 761
a In 761 of 1702 cases intrapartum GBS cultures were performed PPV
was 79%, NPV was 93%.Characteristics of the population studied can also explain
differences in prevalence rates. Women of Caribbean origin
and black women were previously reported to be at greater
risk of colonisation than those of Mexican origin and white
women [2,5,6], which suggests a role for ethnic or genetic
factors. However, other small studies [27–29] have reported
no differences in group B streptococcal prevalence between
any ethnic groups. The women in our study originated from
72 different countries. Differences were found in the
prevalence rates between European, Asian and African
women. These results are in accordance with the findings of
others [2,5,6].
Differences in GBS carriage rates may also be
explained by differences in the socio-economic status of
the study group. A study in New Zealand women showed
an increased risk for GBS carriage in the socially
advantaged [3], whereas Regan et al. [2] found GBS
was less common among women with a higher education.
In our study, we registered postal codes and related socio-
economic status to the neighbourhood. Even when
calculating prevalences for the poor and wealthy neigh-
bourhoods separately and using different levels of income,
we could not find any relation between socio-economic
status and GBS carriage. An explanation for this might be
that in our population the higher income group was quite
small compared to the other groups.
Numerous studies have documented that the accuracy of
prenatal screening cultures in identifying intrapartum
colonisation status can be enhanced by careful attention
to the timing of cultures, the anatomic sites swabbed and the
laboratory procedures used for culture and detection of the
organisms [9]. Swabbing both the lower vagina and the
rectum (through the anal sphincter) substantially increases
the yield compared with sampling only the cervix or
sampling the vagina without swabbing the rectum [30].
Isolation rates will be increased by approximately 10–15% if
the lower genital and anorectal areas are sampled rather than
only the upper vagina and cervix [31].
Yow et al. [14], Kubota [23] and others [15,25] performed
only vaginal or cervicovaginal swabs and found prevalences
between 6% and 14.2%, whereas rectovaginal cultures done
in several other studies [3,8,16,21,24,26] revealed higher
rates between 19.4% and 31%, similar to the 21% found in
our study.
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numerous micro-organisms, the use of selective enrichment
broth is recommended to maximise the isolation of GBS and
to avoid the overgrowth of other organisms. When direct
agar plating is used instead of selective enrichment broth, as
many as 50% of woman who are GBS carriers have false-
negative culture results [32]. Ferrieri et al. [13] and Kubota
[23] did not use selective culture medium and only found
prevalence rates of 5.6% and 11.4%, respectively, whereas
studies that used selective medium reported rates of 19.8%
[16] and 18.6% [2].
Discordant results are reported regarding the effects of
age and parity on GBS prevalence [5,14,27,28,33,34]. In
various studies [27,29,35,36] no significant differences in
colonisation rates were noted on the basis of age or parity,
but increasing age [5] and parity [5,14] have also sometimes
been associated with lower rates of carriage. However,
Regan et al. [2] described GBS carriage as being more
common among older women and women of lower parity. In
our study we found no association between colonisation and
age or parity.
Although the importance of infection as a cause of
preterm delivery is gaining recognition, little is known about
the role of GBS infection in miscarriages. McDonald and
Chambers [37] stated that GBS was a key pathogen in
unsuspected intrauterine infections underlying spontaneous
midgestation abortions. The study of Daugaard et al. [38]
demonstrated an association between the occurrence of
group B Streptococci in the urine and cervix and late
spontaneous abortions, but El Kersh et al. [24] found no
correlation with a history of repeated spontaneous mis-
carriages. We did not find any relation between women who
had a history of miscarriages and GBS carriage, but at this
point our population is selected since we only screened
almost term pregnant women.
Collection of cultures between 35 and 37 weeks’
gestation is recommended to improve the sensitivity and
specificity of the identification of women who are colonised
at the time of delivery [4,31].
Serial cultures done in antenatal patients suggest that
women may be intermittent carriers of group B Streptococci
and demonstrate that concordance with intrapartum culture
status improves as the interval between antenatal cultures
and delivery is shortened [4]. Yancey et al. [4] found in a
population with 26.5% carriage a positive predictive value of
87% and a negative predictive value of 96%, when cultures
were done within 6 weeks before delivery. To improve the
accuracy of antenatal cultures, the Centres for Disease
Control and Prevention has suggested that the collection of
these cultures should occur at 35–37 weeks’ gestation
instead of earlier in pregnancy [39]. In our study we cultured
761 women again on admission for delivery and then
calculated the positive and negative predictive values of the
first culture for carriage during labour. The intention to
reculture all GBS positive women and 400 of GBS negative
women during labour was not fulfilled, probably because ofhectic in the labourrooms and lack of attention to the
studyprotocol.
The PPVof 79% and the NPV of 93% in our study is low
compared to other studies and probably would have been
higher if we recultured all initially GBS positive women
during labour. Both our results and the somewhat higher but
still low predictive values of others underline the need for
rapid tests to detect GBS colonisation status. These bedside-
tests might obviate the need for antenatal culture-based
screening if their sensitivity and specitivity are comparable
to culture in selective broth media and they yield results
rapidly enough to permit the administration of adequate
intrapartum antibiotic prophylaxis to women detected as
carriers [9]. Thus far, these tests have not been reliable
enough to be used as an alternative to rectovaginal cultures.
In the USA, the screening-based strategy is recom-
mended since 2002 [9]. This recommendation is based on
data found in a recent study of comparison of screening- and
risk factor-based strategies. The conclusion of this study was
that the screening-based strategy was over 50% more
effective than the risk factor-based strategy [40]. Manage-
ment strategy depends on local factors like the percentage of
GBS carriers and the percentage of pregnant women with
perinatal risk factors within the population, the organisation
of perinatal care and the local availability of laboratory
facilities.
The choice for a preventive strategy should be based on
rationality, cost-effectiveness and the current knowledge and
possibilities [11]. Since the GBS prevalence found in our
Dutch studypopulation is more or less similar to prevalences
in the USA, the present Dutch recommended risk factor-
based strategy for GBS disease prevention should be
reconsidered.
We show that it is not possible to identify a group of
pregnant women at high risk for GBS colonisation with
regard to age, parity or socio-economic factors. There are
ethnic differences between colonised and noncolonised
women. We demonstrated that positive and negative
predictive values of antenatal genital group B Streptococci
cultures at 35–37 weeks’ gestation for intrapartum GBS
carriage are lower than previously reported.
Results of this study can be useful in the process of
finding the best preventive strategy for neonatal GBS-
disease in The Netherlands.Acknowledgements
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